• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.50% Nasdaq Up1.55%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    117.67 Up 1.59(1.37%) 11:58AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 25,548   25,106   21,837  
    Cost of Revenue -   -   -  
    Gross Profit 25,548   25,106   21,837  
    Operating Expenses
    Research Development54,502  41,037  31,253  
    Selling General and Administrative9,929  7,064  7,215  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (38,883) (22,995) (16,631)
    Income from Continuing Operations
    Total Other Income/Expenses Net55  69  132  
    Earnings Before Interest And Taxes(38,828)(22,926)(16,499)
    Interest Expense -   -   -  
    Income Before Tax(38,828)(22,926)(16,499)
    Income Tax Expense579  (2,824)7,207  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(39,407)(20,102)(23,706)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (39,407) (20,102) (23,706)
    Preferred Stock And Other Adjustments(4,162)(7,190)(3,100)
    Net Income Applicable To Common Shares (43,569) (27,292) (26,806)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.